Evidence map›Paper›PMID 34697648›Full record

ArticleMikrochimica acta2021

Point-of-care testing of butyrylcholinesterase activity through modulating the photothermal effect of cuprous oxide nanoparticles.

Jinzhu Ma, Lili Ma, Lili Cao, Yuming Miao, Jiangxue Dong, Yu-E Shi, Zhenguang Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 10 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jinzhu MaKey Laboratory of Chemical Biology of Hebei Province, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis, Ministry of Education, College of Chemistry & Environmental Science, Hebei University, Baoding, 071002, China.
Lili MaKey Laboratory of Chemical Biology of Hebei Province, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis, Ministry of Education, College of Chemistry & Environmental Science, Hebei University, Baoding, 071002, China.
Lili CaoKey Laboratory of Chemical Biology of Hebei Province, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis, Ministry of Education, College of Chemistry & Environmental Science, Hebei University, Baoding, 071002, China.
Yuming MiaoKey Laboratory of Chemical Biology of Hebei Province, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis, Ministry of Education, College of Chemistry & Environmental Science, Hebei University, Baoding, 071002, China.
Jiangxue DongKey Laboratory of Chemical Biology of Hebei Province, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis, Ministry of Education, College of Chemistry & Environmental Science, Hebei University, Baoding, 071002, China.
Yu-E ShiKey Laboratory of Chemical Biology of Hebei Province, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis, Ministry of Education, College of Chemistry & Environmental Science, Hebei University, Baoding, 071002, China. shiyue1220@163.com.
Zhenguang WangKey Laboratory of Chemical Biology of Hebei Province, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis, Ministry of Education, College of Chemistry & Environmental Science, Hebei University, Baoding, 071002, China. zwang65-c@my.cityu.edu.hk.ORCID http://orcid.org/0000-0003-2001-5165
Hebei University · CN

Funding

Natural Science Foundation of Hebei Province B2019201067One Hundred Talent Project of Hebei Province E2019050011Outstanding Youth Project of Natural Science Foundation of Hebei Province B2020201060Science and Technology Project of Hebei Education Department BJ2020033Young Scientists Fund 21804030Young Scientists Fund 22007027
6 · The paper itself

Abstract

Butyrylcholinesterase (BChE) is an important indicator for clinical diagnosis of liver dysfunction, organophosphate toxicity, and poststroke dementia. Point-of-care testing (POCT) of BChE activity is still a challenge, which is a critical requirement for the modern clinical diagnose. A portable photothermal BChE assay is proposed through modulating the photothermal effects of Cu

Indexed as

Point-of-Care TestingButyrylcholinesteraseCholineCopperEnzyme AssaysHumansInfrared RaysInsecticidesLimit of DetectionMetal NanoparticlesParaoxonSulfidesTemperaturebutyrylcholineButyrylcholinesteraseCholineCoppercuprous oxideInsecticidesParaoxonsodium bisulfideSulfidesButyrylcholinesteraseCuO nanoparticlesCuprous oxideFluorescence detectionPhotothermal effectPoint-of-care testing

Identifiers

PMID34697648
OpenAlexW3209553625

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.